Pressure BioSciences, Inc. Discusses Commercialization of Their Revolutionary UST Platform and Their Planned 2022 Uplisting with The Stock Day Podcast

<div>The Stock Day Podcast welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or “the Company”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services for the worldwide life sciences and other industries. President and CEO of the Company, Mr. Richard T. Schumacher, joined Stock Day host Mr. Everett Jolly. </div>